We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 877 results
  1. The effects of laser cane cues on the freezing of gait of Parkinson’s disease patients: can increasing the laser light beam width play a role?

    Introduction

    Freezing of gait can be seen in a significant number of people with Parkinson’s disease. Disappointingly, the classic standard treatment...

    Mehri Salari, Ronak Rashedi, ... Masoud Etemadifar in Acta Neurologica Belgica
    Article 26 June 2024
  2. Metal Chelators as a Potential Therapeutic Agent for Alzheimer’s Disease

    Alzheimer’s disease (AD) is a neurological condition that causes behavioural abnormalities and a progressive decline in intellectual abilities....
    Bhaskar Dewangan, Kunal Kumar, ... Bichismita Sahu in Natural Product-based Synthetic Drug Molecules in Alzheimer's Disease
    Chapter 2023
  3. Plasma MicroRNA (miRNA)s as Novel Markers of Nonalcoholic Fatty Liver Disease

    Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive fat build-up in the liver without any other evident causes of chronic liver...
    Ulas Emre Akbulut in Biomarkers in Nutrition
    Living reference work entry 2022
  4. A Eu-MOF-Based Fluorescent Sensing Probe for the Detection of Tryptophan and Cu2+ in Aqueous Solutions

    Abnormal tryptophan (Trp) metabolism can be used as an important indicator of chronic hepatitis, paranoia, Parkinson’s disease and other diseases....

    Yafei Gong, Yan Fu, Dawei Lou in Journal of Fluorescence
    Article 28 February 2024
  5. Plasma MicroRNA (miRNA)s as Novel Markers of Nonalcoholic Fatty Liver Disease

    Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive fat build-up in the liver without any other evident causes of chronic liver...
    Ulas Emre Akbulut in Biomarkers in Nutrition
    Reference work entry 2022
  6. Disease progression strikingly differs in research and real-world Parkinson’s populations

    Characterization of Parkinson’s disease (PD) progression using real-world evidence could guide clinical trial design and identify subpopulations....

    Brett K. Beaulieu-Jones, Francesca Frau, ... Clemens R. Scherzer in npj Parkinson's Disease
    Article Open access 13 March 2024
  7. An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is the commonest cause of chronic liver disease worldwide and represents an unmet...

    Timothy J. Kendall, Maria Jimenez-Ramos, ... Jonathan A. Fallowfield in Nature Medicine
    Article Open access 30 October 2023
  8. Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease

    Changes in the transition metal homeostasis in the brain are closely linked with Alzheimer’s disease (AD), including intraneuronal iron accumulation...

    Raghuraj Singh, Archna Panghal, ... Ajay G. Namdeo in Molecular Neurobiology
    Article 29 May 2024
  9. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial

    Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with no approved treatment. MAESTRO-NAFLD-1 was a 52-week randomized,...

    Stephen A. Harrison, Rebecca Taub, ... Mustafa R. Bashir in Nature Medicine
    Article Open access 16 October 2023
  10. Glial Cells as Key Orchestrators of Neural Degeneration in Basal Ganglia Disorders

    The congregation of nuclei in the forebrain, diencephalon and midbrain called ‘basal ganglia’ forms an important structure for neural signals...
    Bidisha Bhaduri, Phalguni Anand Alladi in The Biology of Glial Cells: Recent Advances
    Chapter 2022
  11. Specific immune status in Parkinson’s disease at different ages of onset

    Recent evidence suggests that innate and adaptive immunity play a crucial role in Parkinson’s disease (PD). However, studies regarding specific...

    Jun Tian, Shao-Bing Dai, ... Jia-Li Pu in npj Parkinson's Disease
    Article Open access 10 January 2022
  12. Plasma Lipocalin 2 in Alzheimer’s disease: potential utility in the differential diagnosis and relationship with other biomarkers

    Background

    Lipocalin-2 is a glycoprotein that is involved in various physiological and pathophysiological processes. In the brain, it is expressed in...

    Peter Hermann, Anna Villar-Piqué, ... Franc Llorens in Alzheimer's Research & Therapy
    Article Open access 13 January 2022
  13. Role of metals in Alzheimer’s disease

    Metal homeostasis in the central nervous system (CNS) is a crucial component of healthy brain function, because metals serve as enzymatic cofactors...

    Nikita Das, James Raymick, Sumit Sarkar in Metabolic Brain Disease
    Article 27 July 2021
  14. Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers

    Neurodegenerative diseases (NDDs) have been increasing in incidence in recent years and are now widespread worldwide. Neuronal death is defined as...

    Mohammad Azam Ansari, Takshashila Tripathi, ... Muthu Thiruvengadam in Molecular Neurobiology
    Article 15 November 2023
  15. Nutrition and Brain Functions in Health and Disease

    Adequate food consumption of dietary nutrients is vital for normal brain functions. There is considerable proof that dietary nutrition helps in the...
    Chapter 2022
  16. Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson’s disease

    Cognitive impairment in Parkinson’s disease (PD) adversely influences quality of life. There is currently no available biomarker to predict cognitive...

    Ning-Ning Che, Qiu-Huan Jiang, ... Hong-Qi Yang in npj Parkinson's Disease
    Article Open access 09 September 2021
  17. Iron and Neuro-Cognition

    Born as Khem in ancient China, India, and Egypt; chemistry or ALCHEMY has always been there, throughout ancient times- seeking a remedy and...
    Sara Hassan Omar in Brain-Iron Cross Talk
    Chapter 2023
  18. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer’s Disease

    Essential trace metals like zinc (Zn), iron (Fe), and copper (Cu) play an important physiological role in the metabolomics and healthy functioning of...

    Vinay Chaudhari, Siddhi Bagwe-Parab, ... Ginpreet Kaur in Neurotoxicity Research
    Article 27 January 2023
  19. Wilson disease tissue classification and characterization using seven artificial intelligence models embedded with 3D optimization paradigm on a weak training brain magnetic resonance imaging datasets: a supercomputer application

    Wilson’s disease (WD) is caused by copper accumulation in the brain and liver, and if not treated early, can lead to severe disability and death. WD...

    Mohit Agarwal, Luca Saba, ... Jasjit S. Suri in Medical & Biological Engineering & Computing
    Article 05 February 2021
  20. High genetic carrier frequency of Wilson’s disease in France: discrepancies with clinical prevalence

    Background

    Wilson’s disease (WD) is a rare autosomal recessive metabolic disease caused by ATP7B gene mutations tat cause excessively high copper...

    Corinne Collet, Jean-Louis Laplanche, ... Aurélia Poujois in BMC Medical Genetics
    Article Open access 10 August 2018
Did you find what you were looking for? Share feedback.